12 Coronavirus Stocks Racing to the Vaccine

With more than 38 million cases of the novel coronavirus confirmed worldwide, and a current global death toll that surpasses more than 1 million individuals, a future return to normalcy appears to hinge on the development of a safe and effective vaccine. As another flu season draws closer and certain regions are starting to see coronavirus cases spike again, the world’s attention is becoming increasingly fixed on the race to get a vaccine to market.

At the time of this writing, there are more than 40 vaccines being evaluated in various stages of clinical study, while 11 vaccine candidates have made it to late-stage safety and efficacy trials. These 12 coronavirus stocks are some of the most promising leaders in the ongoing vaccine race.

5 Winning Stocks Under $49
We hear it over and over from investors, “I wish I had bought Amazon or Netflix when they were first recommended by the Motley Fool. I’d be sitting on a gold mine!” And it’s true. And while Amazon and Netflix have had a good run, we think these 5 other stocks are screaming buys. And you can buy them now for less than $49 a share! Simply click here to learn how to get your copy of “5 Growth Stocks Under $49” for FREE for a limited time only.